(ONO) onesano S.A. - Ratings and Ratios

Exchange: WAR • Country: Poland • Currency: PLN • Type: Common Stock •

ONO: Dietary Supplements, Animal Nutrition, Cosmetic Raw Materials

onesano S.A. (WAR:ONO), formerly known as Skotan SA, is a Poland-based company specializing in research and development across dietetics, animal nutrition, bioremediation, and agrotechnological processes. Established in 1995 and headquartered in Chorzów, the company rebranded as onesano S.A. in March 2023, reflecting its expanded focus on human and animal health. Their product portfolio includes dietary supplements under the Estrovita brand, such as Yarrowia Equinox, Yarrowia Canifelox, and Yarrowia Farminox, which cater to both human and animal nutrition. Additionally, they offer food additives, functional foods, and cosmetic raw materials, showcasing their commitment to innovation and sustainability in the health and environmental sectors.

onesano S.A. distributes its products through a diverse network, including chain pharmacies, pharmaceutical wholesalers, bio/eko stores, drugstores, e-commerce platforms, zoological networks, veterinary offices, and animal feed producers. This extensive distribution network underscores their strong market presence in Poland and their strategic approach to reaching a broad customer base.

The companys dedication to R&D is central to its operations, driving advancements in bioremediation and agrotechnological processes. This focus on innovation positions them as a key player in sustainable practices, aligning with growing environmental consciousness and regulatory demands.

Ticker Symbol: ONO Exchange: WAR Type: common stock Country Origin: Poland GICS Sub Industry: Commodity Chemicals Average Volume 20d: 13789 Last Price: 1.10 SMA 20: 1.11 SMA 50: 1.05 SMA 200: 1.15 ATR: 0.05 Market Cap: 71.81M PLN P/E: 0.00 P/E Forward: 0.00 P/B: 6.38 P/S: 6.50 RoE: None

3-Month Forecast: Based on the provided data, onesano S.A.s stock (WAR:ONO) is anticipated to experience a bullish trend. The SMA 20 slightly above the last price at 1.11 suggests potential upward momentum. The low ATR of 0.05 indicates minimal volatility, offering stability. However, the high P/B ratio of 6.38 may signal overvaluation, which could impact medium-term performance. Investors should monitor these metrics closely as they may influence the stocks trajectory in the coming months.

Additional Sources for ONO Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

ONO Stock Overview

Market Cap in USD 19m
Sector Basic Materials
Industry Chemicals
GiC Sub-Industry Commodity Chemicals
IPO / Inception

ONO Stock Ratings

Growth 5y -12.2%
Fundamental -
Dividend 0.0%
Rel. Strength Industry -21.4
Analysts -
Fair Price Momentum 0.94 PLN
Fair Price DCF -

ONO Dividends

No Dividends Paid

ONO Growth Ratios

Growth Correlation 3m 70.3%
Growth Correlation 12m -88.8%
Growth Correlation 5y -43.1%
CAGR 5y 11.26%
CAGR/Max DD 5y 0.16
Sharpe Ratio 12m -0.10
Alpha -30.99
Beta 0.09
Volatility 68.38%
Current Volume 0.2k
Average Volume 20d 8.4k
What is the price of ONO stocks?
As of March 13, 2025, the stock is trading at PLN 1.05 with a total of 181 shares traded.
Over the past week, the price has changed by -4.55%, over one month by +0.48%, over three months by +7.14% and over the past year by -24.73%.
Is onesano S.A. a good stock to buy?
Neither. Based on ValueRay Analyses, onesano S.A. is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -12.24 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ONO as of March 2025 is 0.94. This means that ONO is currently overvalued and has a potential downside of -10.48%.
Is ONO a buy, sell or hold?
onesano S.A. has no consensus analysts rating.
What are the forecast for ONO stock price target?
According to ValueRays Forecast Model, ONO onesano S.A. will be worth about 1 in March 2026. The stock is currently trading at 1.05. This means that the stock has a potential downside of -2.86%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 1 -2.9%